Group 1 - The core viewpoint of the article highlights that Shenzhen Silicon-based Bionic Technology Co., Ltd. has been awarded the "Best Innovative Medical Device Company of the Year" at the 9th Medical Health Investment Excellence List by Haoyue Capital, recognizing its outstanding performance in the innovative medical device sector [1][3] - The "Medical Health Investment Excellence List" is a prestigious evaluation created by Haoyue Capital, focusing on the comprehensive strength of investment institutions in the medical health industry, including activity levels, transaction volumes, return performance, and post-investment empowerment [3][4] - Silicon-based Bionic was founded in 2015 and specializes in blood glucose monitoring, utilizing implantable medical hardware technology and AI algorithms to innovate and promote continuous monitoring products globally [4][5] Group 2 - The company has a workforce of nearly 700, led by scientists from prestigious institutions such as Tsinghua University, Peking University, Caltech, Princeton, and the University of Washington, showcasing a strong research and operational management background [4][5] - Its flagship product, the Silicon-based Dynamic CGM, is the second globally and the first in China to use second-generation glucose sensor technology, achieving the highest sales among domestic CGM products for several consecutive years [4][5] - The company has made significant investments in R&D, participating in key national projects and being recognized as a "National High-Performance Medical Device Innovation Center" and a "Potential Technology Unicorn Enterprise" in Shenzhen [5][6] Group 3 - The Chinese medical health industry is experiencing a structural recovery in 2025, with increased financing activity and significant milestone transactions, indicating a shift towards high-quality, international, and value-driven medical innovation [5][6] - Silicon-based Bionic aims to uphold its core value of "Innovating Medical Technology, Serving Public Health" and aspires to become a global leader in chronic disease management innovative medical devices [6]